(Q44081761)

English

Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565

scientific article published on February 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565 (English)

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

author name string

S. Basu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1639431

19 October 2022

A. Sodhi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1639431

19 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1639431

19 October 2022

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Ficb.1992.3

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

http://www.nature.com/articles/icb19923

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

http://www.nature.com/articles/icb19923.pdf

Portable Document Format

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1038/icb.1992.3/fullpdf

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

Immunology & Cell Biology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

70 ( Pt 1)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

15-24

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Purification and characterization of a human tumor necrosis factor from the LuKII cell line

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Lymphotoxins, macrophage cytotoxins, and tumor necrosis factors: an interrelated family of antitumor effector molecules.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Mediation of mouse natural cytotoxic activity by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Immunomodulatory and therapeutic properties of FK-565 in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Activation of human NK cells and monocytes with cisplatin in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Interleukin 1 and T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

Serine esterase in cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

21 January 2018

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteoglycans in secretory granules of NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased release of interleukin-1 from mouse peritoneal macrophages in vitro after cisplatin treatment

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Release of cytolytic factor(s) by murine macrophages in vitro on treatment with cis-platin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FICB.1992.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of interleukin-1 and tumor necrosis factor by cisplatin-treated murine peritoneal macrophages

23

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2

35

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis

36

1 reference

10.1038/ICB.1992.3

https://api.crossref.org/works/10.1038/ICB.1992.3

19 October 2022

Identifiers

10.1038/ICB.1992.3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44081761&oldid=1755514079"